Oncology & Cancer

Immune therapy takes a 'BiTE' out of brain cancer

Building on their research showing that an exciting new form of immunotherapy for cancer has activity in patients with glioblastoma, the most common and most deadly form of brain cancer, Massachusetts General Hospital (MGH) ...

Oncology & Cancer

Unlocking therapies for hard-to-treat lung cancers

Now, a new Salk Institute study, published on July 24, 2019, in the journal Science Advances, shows that researchers could target these hard-to-treat cancers by pursuing drugs that keep a cellular "switch," called CREB, from ...

Sports medicine & Kinesiology

Does platelet-rich plasma therapy lower risk of meniscus repair

The use of platelet-rich plasma therapy can reduce the risk of a second meniscus failure after operation but does not seem to protect patients who have had surgery to repair an anterior cruciate ligament, according to research ...

Neuroscience

Glowing brain cells illuminate stroke recovery research

A promising strategy for helping stroke patients recover, transplanting neural progenitor cells to restore lost functions, asks a lot of those cells. They're supposed to know how to integrate into a mature (but damaged) brain. ...

Oncology & Cancer

Uridine diphosphate glucose found to dampen lung cancer metastasis

In a study published online in Nature on June 26, research teams led by Dr. Yang Weiwei at the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (CAS) and Dr. Li Guohui from the Dalian Institute ...

page 30 from 40